# Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome

> **NCT00272311** · PHASE4 · COMPLETED · sponsor: **Florida Atlantic University** · enrollment: 70 (actual)

## Conditions studied

- Cardiovascular Diseases
- Metabolic Syndrome X
- Atherosclerosis

## Interventions

- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT00272311
- **Lead sponsor:** Florida Atlantic University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272311, "Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00272311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*